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Invasive infection with organisms of the Mycobacterium avium complex (MAC) is common among patients
with advanced human immunodeficiency virus infection. In previous studies, we analyzed multiple individual
colonies of MAC isolated from specimens obtained at the same time and observed that 14 to 20%7v of patients
are simultaneously infected with more than one strain. In this study, we examined sequential isolates from 12
patients with AIDS who had two or more MAC isolates available from clinical specimens collected more than
1 week apart; the intervals between the first and last specimens ranged from 8 to 192 (median, 46) days. For
each isolate, restriction digests of genomic DNA were analyzed by pulsed-field gel electrophoresis; DNA was
prepared by using a protocol, described here in detail, which had been optimized for conditions of bacterial
growth and lysis. The pulsed-field gel electrophoresis analysis identified four patients (33%) infected with two
different MAC strains. Both M. avium and M. intracelulare were cultured from blood specimens from two
patients. In each of the four patients, the second strain was identified from a culture taken within 14 days of
the initial study isolate, and in three of these patients, the first strain was detected again in a subsequent
culture. These observations suggest that the presence of two different strains among isolates from sequential
cultures may reflect ongoing polyclonal infection. We conclude that polyclonal infection with MAC is common
among patients with AIDS. The identification of such infections may be critical in the development of effective
treatments.
Infections with organisms of the Mycobacterium avium com-
plex (MAC) occur in up to 40% of patients with advanced
human immunodeficiency virus (HIV) infection (14); -95% of
the isolates represent M. avium strains (19). Precise epidemi-
ologic studies of these and other nontuberculous mycobacterial
infections require a reproducible and highly discriminatory
method for differentiating individual strains (9). We and other
investigators have described the use of pulsed-field gel elec-
trophoresis (PFGE) to resolve MAC, M. paratuberculosis, M.
fortuitum, and M. tuberculosis strains (1, 2, 7, 12, 20). On the
basis of a detailed examination of the conditions for bacterial
growth and lysis reported here, we have developed a protocol
for consistent and efficient isolation of mycobacterial genomic
DNA suitable for PFGE studies. We describe here the use of
this protocol to perform PFGE analyses of 55 MAC isolates
from 12 patients, from each of whom two or more positive
cultures were obtained at least 1 week apart. These studies
identified four patients (33%) infected with two different MAC
strains isolated from sequential cultures, including two patients
infected with M. avium and M. intracellulare isolates.
* Corresponding author. Mailing address: Research Service (151),
VA Medical Center, 150 So. Huntington Avenue, Boston, MA 02130.
Phone: (617) 278-4416. Fax: (617) 739-6394. Electronic mail address:
rarbeit@bu.edu.
t Present address: Department of Clinical Microbiology, Strong
Memorial Hospital, Rochester, NY 14642.
MATERIALS AND METHODS
Bacterial isolates. ATCC 35718 (TMC 702, kindly provided
by J. 0. Falkinham), an M. avium serovar 3 strain cultured
from a cervical lymph node of a child, was used for the studies
to optimize the isolation of genomic DNA. Patients with
cultures yielding MAC from sterile sites (blood, bone marrow,
and liver) were identified from clinical microbiology laboratory
records or from an international study of MAC epidemiology
(1); isolates were retrieved for those patients from whom two
or more positive cultures were obtained at least 1 week apart.
Clinical isolates were obtained from the Mycobacteriology
Division, Massachusetts State Laboratory (n = 21) and the
clinical microbiology laboratory of the Brigham and Women's
Hospital (n = 12) and as part of the MAC epidemiology study
(n = 22).
Preparation of DNA in situ in agarose. Bacteria were
inoculated from slants into 10 ml of modified Middlebrook
7H9 broth prewarmed to 37°C; this broth is composed of 4.7 g
of Middlebrook 7H9 powder (BBL Microbiology Systems,
Cockeysville, Md.) per ml; 0.5 M sucrose, 0.05% (wt/vol)
Tween 80, 0.2% (wt/vol) D-glucose, and 10% (vol/vol) oleic
acid-albumin complex (BBL). The solutions of 2x Middle-
brook powder-0.1% Tween 80, 1 M sucrose, and 4 g of
D-glucose per liter were autoclaved separately. After cooling,
these solutions were mixed with 10% (vol/vol) oleic acid-
albumin complex under aseptic conditions, aliquoted into
15-ml glass screw-cap tubes, and stored at 4°C.
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The broth cultures were incubated at 37°C with rotation (20
to 30 rpm) for 4 to 14 days to an oytical density at 600 nm
(OD600) of 0.20 (-1 x 10' to 2 x 10 CFU/ml). One milliliter
of 1ox ACT solution (1 mg of ampicillin per ml, 10 mg of
D-cycloserine per ml, 10 mg of D-threonine per ml) was then
added, and the cultures were reincubated for an additional 12
to 18 h. The cultures were centrifuged at 1,000 x g (calculated
at the pellet) for 20 min at 4°C, the media were aspirated, and
the bacteria were resuspended in 1/50 of the culture volume in
TS buffer (50 mM Tris, 0.5 M sucrose, pH 7.6). The suspension
was carefully transferred to a microcentrifuge tube, immedi-
ately frozen in dry ice-ethanol, and then either thawed on wet
ice for subsequent processing or stored at -70°C.
After thawing, the cell suspension was immediately mixed
with an equal volume of 1.3% molten 60°C InCert agarose
(FMC Bioproducts, Rockland, Maine) in TEN buffer (50 mM
Tris, 250 mM EDTA, 200 mM NaCl, pH 7.6). To prevent
crystallization of 250 mM EDTA that occurred with boiling,
2x TEN buffer was warmed to 60°C and mixed with an equal
volume of 2.6% molten agarose previously dissolved in water
in a boiling water bath. The cell-agarose mixture was quickly
dispensed into plug molds and allowed to solidify at 4°C.
Subsequent treatment with lysozyme and proteinase K was
performed as previously described (10).
PFGE analysis. Plugs were restriction digested overnight
with 20 U of AseI (New England Biolabs, Beverly, Mass.) as
previously described (10), and the restriction fragments were
separated in a 1% agarose gel (Seakem GTG; FMC) on a
CHEF DRII apparatus (Bio-Rad, Richmond, Calif.) at 15°C
for 22 h with pulse times of 1 to 40 s ramped linearly.
RESULTS
Optimal isolation of mycobacterial genomic DNA for PFGE.
Preparation of mycobacterial DNA in agarose is complicated
primarily by the long bacterial generation time and difficulty in
lysing the cell wall; the latter step is critical for isolation of
DNA suitable for restriction digestion. Mycobacteria grown in
liquid media typically clump because of the hydrophobic
lipoarabinomannan layer, which also protects the underlying
peptidoglycan layer from cell wall-lysing enzymes (13). Clump-
ing was decreased in media supplemented with Tween 80 at
0.05% and further limited by Tween 80 at 0.1%, although the
higher concentration resulted in slightly decreased mycobacte-
rial growth rates. It is of note that mycobacteria grown in liquid
medium, frozen at -70°C in 80% modified Middlebrook 7H9
broth-20% glycerol, and then subcultured into modified
Middlebrook 7H9 broth with either concentration of Tween 80
demonstrated minimal clumping.
Treatment of growing mycobacteria with ampicillin and
D-cycloserine has been reported to increase their susceptibility
to lysing agents (7, 20); we also included D-threonine, another
inhibitor of cell wall synthesis, prior to cell lysis. Several hours
after the addition of ACT, bacterial growth ceased (as assessed
spectrophotometrically) and cellular debris accumulated in the
tubes. Increasing the duration and/or concentration of ACT
treatment resulted in increased debris and decreased DNA
yields. This suggested that the mycobacterial subpopulation
affected by ACT was osmotically unstable and susceptible to
premature lysis and DNA degradation. To protect the osmot-
ically fragile cells, we tested sucrose, sodium succinate, sorbi-
tol, and glycerol as osmotic stabilizers in the resuspension
buffer (data not shown). Only 0.5 M sucrose consistently
protected the cells from premature lysis without inhibiting
bacterial growth.
Multiple parameters were varied to determine the optimal
TABLE 1. Modifications of the cell growth and lysis protocol
used to isolate mycobacterial DNA
Use for Fig. 1, lane:
Protocol modification'
1 2 3 4 5 6 7 8
ACT added to growth media + + + + + + + +
Sucrose in growth media - - - + + + + +
Sucrose in resuspension buffer + + + + + + +
Freezing-thawing prior to - - + - + + - +
enzymatic lysis
Zymolase in lysis solution - + - - - + +
Lysozyme in lysis solution + + + + + - - +
" Protocol modifications are described in Materials and Methods. A plus sign
indicates that the reagent or procedure was included in preparing the DNA
demonstrated in the corresponding lane in Fig. 1, and a minus sign indicates that
it was omitted.
conditions for bacterial lysis and DNA yield; several protocol
modifications are summarized in Table 1 and illustrated in Fig.
1. The best results were obtained by adding 0.5 M sucrose to
both the growth medium and the resuspension buffer (Fig. 1,
lanes 4 through 7); resuspension of mycobacteria in the
Tris-sodium chloride buffer routinely used for other organisms
(10) resulted in premature lysis and poorer DNA yields (Fig. 1,
lane 5 versus lane 8).
A freeze-thaw cycle, used to prepare protoplasts of gram-
positive bacilli (15), has been incorporated into other protocols
for the isolation of mycobacterial DNA to synchronize the
1 2 3 4 5 6 7 8
FIG. 1. PFGE of AseI restriction digests of whole chromosomal
DNA of M. avium ATCC 35718 (serovar 3). The lane numbers
correspond to the protocol modifications indicated in the correspond-
ing columns of Table 1. See the text for details.
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processing of bacteria with different growth rates (7, 18). In our
experiments, freezing-thawing increased the quantity of DNA
(Fig. 1, lanes 3, 5, and 6 versus lanes 1, 4, and 7, respectively);
however, the effect was least apparent for cells grown in the
presence of sucrose (Fig. 1, lane 5 versus lane 4). Additional
experiments demonstrated that for cultures grown and resus-
pended in sucrose and subsequently treated with lysozyme, the
DNA yields obtained by pretreatment with freezing-thawing
alone were comparable to those obtained by ACT treatment
alone, with no consistent benefit from using both treatments
(data not shown). Thus, the cell population(s) susceptible to
freezing-thawing may be similar to those susceptible to ACT
treatment.
To minimize the activity of endogenous endonucleases that
would degrade the DNA, the bacterial suspension was main-
tained at 4°C after thawing and mixed as soon as possible with
molten agarose in EDTA buffer. Several enzymes, including
zymolase, lysostaphin, subtilisin, and lysozyme, were tested for
the ability to disrupt the mycobacterial cell wall (data not
shown). The combination of lysozyme and zymolase has been
used for mycobacterial lysis (7); however, we observed that
DNA yields obtained with lysozyme treatment alone were
better than or comparable to those obtained with either
zymolase alone (Fig. 1, lanes 4 and 5 versus lanes 7 and 6,
respectively) or zymolase and lysozyme (Fig. 1, lane 1 versus
lane 2) (additional data not shown). Note that efforts to
increase cell lysis (by freezing-thawing or by treatment with
multiple enzymes) without providing osmotic protection for
the organisms during growth and ACT treatment resulted in
increased DNA yields but with marked streaking of the DNA
digests during electrophoresis (Fig. 1, lanes 1 and 3 versus
lanes 4 and 5, respectively). We speculate that in the absence
of osmotic stabilization, a greater fraction of the cells har-
vested are resistant to lysis and that such intact cells interfere
with the migration of the DNA that is released and digested.
In summary, as detailed in Materials and Methods, we
observed that the optimal protocol for obtaining mycobacterial
DNA in agarose for subsequent PFGE analysis included
treatment of growing cultures with ACT, addition of 0.5 M
sucrose to both the broth medium and resuspension buffer,
freezing-thawing after resuspension, and treatment of cells in
agarose with lysozyme.
Analysis of sequential isolates from HIV-infected patients
with disseminated MAC. We used the above-described proto-
col to analyze 55 isolates from 12 HIV-infected individuals who
had disseminated MAC and from whom two or more isolates
were available from specimens obtained at least 1 week apart
(Table 2). There were two to five (median, three) positive
culture specimens per patient. Only one colony was available
from most of the primary cultures; for eight cultures from four
patients, multiple colonies were collected as part of the MAC
epidemiology study (1). (These four patients are included in
this report because additional isolates were available from
clinical cultures taken outside of the epidemiology study.)
There were 2 to 10 (median, 4) isolates per patient. The
intervals from the first to the last available isolates ranged from
8 to 192 (median, 46) days.
Four patients (33%) were infected with two different MAC
strains (Table 2 and Fig. 2). For each of these patients, the two
different strains were identified among isolates from the first
two cultures yielding MAC; the time spans between the first
available isolate and the first isolate representing the second
strain ranged from 4 to 14 (median, 6) days. For three of these
patients, the first strain was again detected in a subsequent
culture. Only four patients were receiving antimicrobial agents
expected to have significant activity against MAC (i.e., clar-
ithromycin, ethambutol, clofazimine, amikacin, ciprofloxacin,
or rifampin) at the time any of the specimens were obtained.
Only one of these, patient 1049, had documented polyclonal
disease; the two different strains were both cultured prior to
the institution of antimycobacterial therapy. Patients 1235 and
1236 were infected with the same MAC strain, as defined by
PFGE (Fig. 2); both patients received care at the same
institution. Each of the other study patients was infected with
one or more unique strains. For patients 1235 and 1237,
infected with two different MAC strains, one of the strains was
identified as M. intracellulare (Table 2); all of the other isolates
in this study were identified as M. avium.
DISCUSSION
This report describes an efficient and reliable methodology
for isolating mycobacterial genomic DNA in agarose suitable
for examination by PFGE. We have used this protocol to
analyze genomic DNAs from several mycobacterial species,
including M. avium, M. intracellulare, M. gordonae, M. bovis,
and M. bovis BCG (1, 5). Thus, the technique described here is
generally applicable both to nontuberculosis species and to
those of the M. tuberculosis complex. Several other investiga-
tors have described the use of PFGE to analyze strains of
mycobacteria (2, 4, 7, 12, 20); however, these reports have not
described the basis for specific steps in their protocols.
We observed two factors that were critical for the isolation
of suitable DNA. (i) The yield ofDNA was increased by adding
0.5 M sucrose to the growth medium and to the buffers in
which the cells were resuspended prior to being embedded in
agarose. We believe that the sucrose serves to protect cells that
will be easily lysed in situ in agarose against spontaneous
osmotic lysis in solution. (ii) A freeze-thaw cycle, which has
been included in most protocols to isolate DNA from myco-
bacteria (7, 12, 18, 20), was explicitly confirmed to facilitate
lysis. When processing MAC isolates, we routinely add ACT to
the culture 12 to 18 h prior to harvesting; the cost and effort of
this step are nominal, and although it is not strictly critical for
some strains, it appears to facilitate lysis for others. However,
addition of ACT resulted in poorer DNA yields for M. bovis
and M. bovis BCG (5). Although an early report described the
use of zymolase and lysozyme to lyse organisms cast in agarose
(7), we found that when the cells were suitably prepared (by
ACT pretreatment or freezing-thawing), lysozyme alone pro-
vided sufficient lysis for isolation of high-quality DNA. Conse-
quently, we omit zymolase, which is considerably more expen-
sive than lysozyme and technically more difficult to use because
it tends to precipitate in EDTA solutions.
By using this protocol, we examined 55 isolates from 12
HIV-infected patients for whom two or more MAC isolates
were available with an interval of at least 1 week between the
first and last isolates. We detected two distinct MAC strains in
four patients (33%). In each patient, both strains were identi-
fied in cultures '14 days apart, and in three of the patients, the
index strain was identified in a subsequent culture. These
observations suggest that the presence of two different strains
among isolates from sequential cultures may reflect ongoing
polyclonal infection. For two of the patients infected with two
different MAC strains, the isolates were identified as M. avium
and M. intracellulare. Antimicrobial therapy did not appear to
be a contributing factor in the development of acute polyclonal
infection. However, patient 1049, from whom two different
MAC strains were cultured over 8 days, had a clinical recur-
rence 17 months later while being treated with four antimyco-
bacterial drugs. At that time, he had recurrent MAC bactere-
mia; PFGE analysis of a single isolate identified a third distinct
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TABLE 2. Microbiologic data and concurrent antimicrobial treatments for 12 AIDS patients with multiple MAC isolates cultured over time
Patient No. of days after Source(s) of Patient isolate Antimicrobial treatment
no.' initial culture culture(s) PFGE pattern(s)b at time culture obtainedc
1009 0 Blood A RIF, EMB
Liver
Blood
Bone marrow
Blood, feces
Bone marrow
Blood
Blood
Urine
Bone marrow
A
AAA
A
A A A, A A A
A
AA
A
B
A
RIF, EMB
RIF, EMB, AMK, CIP
INH, RIF, PZA
INH, RIF, PZA
INH, RIF, PZA, CLA
INH, RIF, PZA, CLA
None
None
None
Blood, feces, sputum
Blood
Sputum, feces
Bone marrow
Bone marrow
Blood
Blood
Sputum
Bone marrow
Sputum
Pleural fluid
Blood
Sputum
Blood
Bone marrow
Blood
Blood
Blood
Blood
Blood
Blood
Blood
Blood
Blood
Blood
Blood
A A A, A A A, A
A
A A, A A A
A
A
A
A
A
A
A
A
A
A
A
A
Ad
B B
B
Ad
A
B
B
A
Bd
A
A
Patients 1009 to 1060 were enrolled in the international study of MAC epidemiology (1); the isolates obtained from patient 1009 on day 104 were included in a
previous report (1).
" The PFGE patterns are listed for each of the isolates analyzed for each patient; when multiple colonies were saved from the primary culture and analyzed separately,
the result obtained for each colony is given. The first pattern observed for each patient was designated A; if a different pattern was detected among subsequent isolates
from that patient, it was designated B.
'Antimicrobial agents: RIF, rifampin; EMB, ethambutol; AMK, amikacin; CIP, ciprofloxacin; INH, isoniazid; PZA, pyrazinamide; CLA, clarithromycin.
d The isolates cultured from patient 1235 on days 0 and 49 and from patient 1237 on day 14 were M. intracellulare; all other isolates were M. avium.
strain (data not shown). It is unclear whether this episode of
bacteremia represents a relapse with a strain not detected
among the isolates initially available or infection with a new
strain.
We have previously reported detection of concurrent bacte-
remia with two distinct M. avium strains in 2 (14%) of the first
14 patients enrolled in an international study of MAC epide-
miology (1); those observations reflected a PFGE analysis of
three colonies from a single culture. Among the first 25
patients enrolled in that study for whom multiple colonies have
been examined, we have detected a total of 5 patients (25%)
simultaneously infected with more than one MAC strain
(unpublished data). As noted, the patients reported here
included five patients from the epidemiology study for whom
additional nonstudy isolates were available. These patients had
monoclonal infection on the basis of an analysis of the multiple
colonies available from their study cultures; for each patient,
the same infecting strain was detected among their nonstudy
isolates. Overall, we have identified 9 patients (24%) with
polyclonal infection among 37 patients for whom multiple
isolates have been analyzed.
Mazurek et al. analyzed MAC isolates from nine patients for
6
104
1045 0
32
123
130
1049 0
6
8
1052
1060
0
14
0
192
1212
1213
0
26
0
14
15
1217 0
88
112
1228 0
36
44
1235 0
6
13
49
1236
None
None
None
None
None
None
None
None
None
INH
INH
INH
None
None
None
None
None
None
CLA
None
None
None
None
None
None
None
0
4
11
1237 0
14
56
121
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Patient no.
Day of culture
Pt. PFGE pattern
674 kb -
361 kb-
208 kb -
80 kb -
1212
0 26
A A
1235
0 6 1349
A R RA
1236
0 4 11
A B B
1237
0 1456 121
A B A A
FIG. 2. PFGE of AseI restriction digests prepared from sequential
MAC isolates cultured from patients 1212, 1235, 1236, and 1237. For
each patient, the day of isolation and the PFGE pattern designations
appear above each isolate. The first pattern observed for each patient
was designated A; if a different pattern was detected among subse-
quent isolates from that patient, it was designated B. Patients 1235,
1236, and 1237 were infected with two distinct strains, as resolved by
PFGE; for patient 1212, only one strain was detected. The isolates
obtained from patient 1235 on days 6 and 13 demonstrated a PFGE
pattern (designated 1235B) indistinguishable from that of the isolate
obtained from patient 1236 on day 0 (designated 1236A); these isolates
were considered to represent the same strain. All of the remaining
patterns were distinctly different and were considered to represent
unique MAC strains. The first and last lanes contained SmaI restric-
tion digests of Staphylococcus aureus ATCC 8325, included as molec-
ular size markers. Pt., patient.
whom two or more isolates were available (12). The presence
or absence of HIV infection in these patients was not explicitly
stated. For six patients, only respiratory isolates (spanning 1
day to 2 years) were available. From three patients, at least one
isolate was cultured from blood or bone marrow; isolates from
these patients spanned 1 day to 27 months. Each of the nine
patients was infected with a single unique MAC strain, as
determined by PFGE. AIDS patients infected with two myco-
bacterial species have been previously reported (6, 8, 11, 16),
including one patient with a simultaneous bloodstream infec-
tion due to M. avium and M. intracellulare (3).
The observation that two patients were infected with the
same M. avium strain as resolved by PFGE, suggests a possible
common-source exposure. Although a detailed epidemiologic
investigation was not performed, both patients are known to
have been treated at the same hospital prior to the onset of
invasive MAC disease, suggesting possible nosocomial acqui-
sition. In the course of our prospective studies, we have
recently identified similar clusters of patients infected with the
same M. avium strain (17). For those patients, the infecting
strain was recovered from the hot water system of the hospital
at which they were treated. We are currently examining the
water supply of the hospital to which patients 1235 and 1237 of
this report were both admitted.
We conclude that patients with advanced AIDS may com-
monly be infected with multiple MAC strains. Such polyclonal
infection can be detected by using PFGE to analyze either
multiple colonies from individual cultures or single colonies
from multiple separate cultures obtained over time. However,
the true prevalence of polyclonal infection among patients with
AIDS has not been accurately determined nor has the impact
of these infections on the response to antimycobacterial treat-
ment been defined. The possibility that patients with AIDS are
infected with more than one MAC strain, either concurrently
or over time, must be considered in designing and evaluating
treatment studies.
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